Evidence map›Paper›PMID 22037307›Full record

ArticleNature2011

Control of Drosophila endocycles by E2F and CRL4(CDT2).

Norman Zielke, Kerry J Kim, Vuong Tran, Shusaku T Shibutani, Maria-Jose Bravo, Sabarish Nagarajan, Monique van Straaten, Brigitte Woods, George von Dassow, Carmen Rottig and 4 more

Open access · greenAbstract read
In one paragraph

Article in Nature, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 111 papers.

0numbers the graph read from it
0cells of the map it votes in
111citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

111 citing papers in PubMed, 161 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Morphological innovation without gene co-option: thebioRxiv : the preprint server for biology · 2026
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Long noncoding RNAScience advances · 2024
    Article
  17. Article
  18. Cell cycle re-entry in the agingbioRxiv : the preprint server for biology · 2024
    Article
  19. Post-eclosion growth in thebioRxiv : the preprint server for biology · 2024
    Article
  20. Article

51 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 4 countries.

Norman ZielkeGerman Cancer Research Center (DKFZ)-Zentrum für Molekulare Biologie der Universität Heidelberg Alliance, Im Neuenheimer Feld 282, 69120 Heidelberg, Germany.
Kerry J Kim
Vuong Tran
Shusaku T Shibutani
Maria-Jose Bravo
Sabarish Nagarajan
Monique van Straaten
Brigitte Woods
George von Dassow
Carmen Rottig
Christian F Lehner
Savraj S Grewal
Robert J Duronio
Bruce A Edgar
North Seattle College · USUniversity of Calgary · CAUniversity of North Carolina at Chapel Hill · USUniversity of Washington · USUniversity of Zurich · CHDKFZ-ZMBH Alliance · DEFred Hutch Cancer Center · USGerman Cancer Research Center · DE

Funding

GENE NETWORKS: FROM MOLECULES TO MECHANISTIC MODELSP50GM066050 · NIGMS · UNIVERSITY OF WASHINGTON · PI ODELL, GARRETT M · 2002 to 2010
$12.0M
Growth Regulation during Drosophila DevelopmentR01GM051186 · NIGMS · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ROHRSCHNEIDER, LARRY RAY · 1994 to 2011
$5.2M
GENETIC ANALYSIS OF E2F FUNCTION DURING DEVELOPMENTR01GM057859 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DURONIO, ROBERT J · 1999 to 2012
$3.5M
Diversity Action Plan: UW GenOM ProjectR25HG007153 · NHGRI · UNIVERSITY OF WASHINGTON · PI EICHLER, EVAN · 2013 to 2020
$2.3M
CIHR MOP-86622NHGRI NIH HHS R25 HG007153NIGMS NIH HHS 5 P50GM66050NIGMS NIH HHS GM51186NIGMS NIH HHS GM57859NIGMS NIH HHS P50 GM066050NIGMS NIH HHS R01 GM051186NIGMS NIH HHS R01 GM057859
6 · The paper itself

Abstract

Endocycles are variant cell cycles comprised of DNA synthesis (S)- and gap (G)-phases but lacking mitosis. Such cycles facilitate post-mitotic growth in many invertebrate and plant cells, and are so ubiquitous that they may account for up to half the world's biomass. DNA replication in endocycling Drosophila cells is triggered by cyclin E/cyclin dependent kinase 2 (CYCE/CDK2), but this kinase must be inactivated during each G-phase to allow the assembly of pre-Replication Complexes (preRCs) for the next S-phase. How CYCE/CDK2 is periodically silenced to allow re-replication has not been established. Here, using genetic tests in parallel with computational modelling, we show that the endocycles of Drosophila are driven by a molecular oscillator in which the E2F1 transcription factor promotes CycE expression and S-phase initiation, S-phase then activates the CRL4(CDT2) ubiquitin ligase, and this in turn mediates the destruction of E2F1 (ref. 7). We propose that it is the transient loss of E2F1 during S phases that creates the window of low Cdk activity required for preRC formation. In support of this model overexpressed E2F1 accelerated endocycling, whereas a stabilized variant of E2F1 blocked endocycling by deregulating target genes, including CycE, as well as Cdk1 and mitotic cyclins. Moreover, we find that altering cell growth by changing nutrition or target of rapamycin (TOR) signalling impacts E2F1 translation, thereby making endocycle progression growth-dependent. Many of the regulatory interactions essential to this novel cell cycle oscillator are conserved in animals and plants, indicating that elements of this mechanism act in most growth-dependent cell cycles.

Indexed as

AnimalsCell CycleDrosophila melanogasterDrosophila ProteinsE2F Transcription FactorsFemaleMaleSalivary GlandsS PhaseTranscription FactorsUbiquitin-Protein Ligase ComplexesUbiquitin-Protein LigasesCRL4(Cdt2) protein, DrosophilaDrosophila ProteinsE2f1 protein, DrosophilaE2F Transcription FactorsTranscription FactorsUbiquitin-Protein Ligase ComplexesUbiquitin-Protein Ligases

Identifiers

PMID22037307
PMCPMC3330263
OpenAlexW1996533937

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.